David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Proceedings of the Aristotelian Society 108 (1pt3):269-288 (2008)
This paper examines the morality of kidney markets through the lens of choice, inequality, and weak agency looking at the case for limiting such markets under both non-ideal and ideal circumstances. Regulating markets can go some way to addressing the problems of inequality and weak agency. The choice issue is different and this paper shows that the choice for some to sell their kidneys can have external effects on those who do not want to do so, constraining the options that are now open to them. I believe that this is the strongest argument against such markets.
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
Immanuel Kant (1996). Practical Philosophy. Cambridge University Press.
Michael Walzer (1983). Spheres of Justice. Basic Books.
Elizabeth Anderson (1993). Value in Ethics and Economics. Harvard University Press.
Kenneth J. Arrow (1972). Gifts and Exchanges. Philosophy and Public Affairs 1 (4):343-362.
Lawrence Cohen (2003). Where It Hurts: Indian Material for an Ethics of Organ Transplantation. Zygon 38 (3):663-688.
Citations of this work BETA
No citations found.
Similar books and articles
Paul Hughes (2006). A Review Of: “James Stacey Taylor, Stakes and Kidneys: Why Markets in Human Body Parts Are Morally Imperative”. [REVIEW] American Journal of Bioethics 6 (2):93-94.
Ph D. Amy E. White (2005). Review Essay: Stakes and Kidneys: Why Markets in Human Body Parts Are Morally Imperative, by James Stacey Taylor. HEC Forum 17 (4):319-322.
Michael B. Gill & Robert M. Sade (2002). Paying for Kidneys: The Case Against Prohibition. Kennedy Institute of Ethics Journal 12 (1):17-45.
S. J. Kerstein (2009). Autonomy, Moral Constraints, and Markets in Kidneys. Journal of Medicine and Philosophy 34 (6):573-585.
William Kline (2010). Do No Harm: A Defense of Markets in Healthcare. [REVIEW] HEC Forum 22 (3):241-251.
James Stacey Taylor (2006). Why Markets in Proto-Deceptive Goods Should Be Restricted. Journal of Business Ethics 65 (4):325 - 335.
Debra Satz (2007). Liberalism, Economic Freedom, and the Limits of Markets. Social Philosophy and Policy 24 (1):120-140.
David Resnik (2008). Stakes and Kidneys: Why Markets in Human Body Parts Are Morally Imperative. Journal of Moral Philosophy 5 (1):169-170.
Added to index2009-01-28
Total downloads275 ( #3,135 of 1,724,890 )
Recent downloads (6 months)7 ( #93,209 of 1,724,890 )
How can I increase my downloads?